Singapore-based BioMers continues its international expansion by partnering with China Pioneer Pharma Holdings Ltd. The partnership will bring BioMers’ SimpliClear into the Hong Kong market.
Based in Shanghai, Pioneer Pharma is one of the largest marketing, promotion, and channel management providers dedicated to imported pharmaceutical products and medical devices. The company serves more than 20,000 hospitals and other medical institutions across 31 provinces, municipalities, and autonomous regions in China.
According to BioMers, with a high demand for aesthetic orthodontics, Hong Kong represents an ideal opportunity for SimpliClear – a translucent braces system that offers aesthetically conscious patients an option to meet their treatment needs.
“China Pioneer Pharma Holdings Ltd offers an extensive sales and distribution network, which is a great platform for our highly innovative product,” said George Aliphtiras, CEO BioMers. “The partnership brings the potential for further collaboration in other countries in the region in the very near future.”
